Skip to main content

COVID-19 Topic Center

Diabetes News

News
The US Food and Drug Administration has approved the sodium-glucose co-transporter 2 (SGLT2) inhibitor Steglatro (ertugliflozin) for the improvement of glycemic control in adults with type 2 diabetes. The drug is available in once-daily 5 mg and 15 mg oral tablets and is approved as an add-on…
News
Sun Pharmaceutical Industries Inc. is recalling 4- and 16-ounce bottles of cherry-flavored Riomet (metformin hydrochloride) oral solution, 500 mg/5 mL (NDC 10631-206-01, NDC 10631-206-02), because of microbial contamination. The recall was included in the December 20, 2017, US Food and Drug…
News
By Toni Clarke (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S’s diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co’s Trulicity. Ozempic, known generically as semaglutide, will compete with others in a class…
News
Actavis Inc is pulling 499,320 units of Glipizide extended-release tablets, Rx Only, from the US market because of failed dissolution specifications (http://bit.ly/2mbIXvb). “Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point,”…
News
By David L. Levine NEW YORK (Reuters Health) - In nonoperable patients with symptomatic primary hyperparathyroidism (PHPT), thiazides may be used to treat hypercalciuria without significantly exacerbating hypercalcemia, a retrospective study suggests. Patients on thiazides also saw a drop in…
News
The US Food and Drug Administration (FDA) has announced class-wide labeling changes for all prescription testosterone products regarding the risks associated with abuse and dependence. The new warning included in the Abuse and Dependence section of the label will “alert prescribers to the abuse…
News
By Ben Hirschler LONDON - Two problematic diabetes drugs associated with worrying side effects may reduce the risk of patients developing Parkinson's disease, offering a springboard for further research, scientists said on Tuesday. An analysis of more than 160,000 British diabetics found that…
News
By Andrew M. Seaman Millions of blood sugar testing strips may be unneeded by the U.S. veterans who receive the strips through two government insurance programs each year, suggests a new study. There was potential waste in the two insurance programs, researchers found, but the most waste occurred…
Back to Top